Description: MedMira Inc. is a biotechnology company. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company operates through the rapid diagnostic products and services segment. The Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its research focuses on specific areas of the diagnostics market, such as rapid, point-of-care and in vitro sectors. The RVF technology platform includes a three component system: a test cartridge, multi-function buffer and InstantGold Cap. Its technology can be applied in healthcare, research and industrial markets. It offers rapid tests for testing serum, plasma or whole blood specimens. The Company's tests are sold under brands, including Reveal, Multiplo and Miriad. The Company offers rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis.
Home Page: www.medmira.com
MIR Technical Analysis
155 Chain Lake Drive
Halifax,
NS
B3S 1B3
Canada
Phone:
902 450 1588
Officers
| Name | Title |
|---|---|
| Mr. Hermes Chan | Co-Founder, CEO, Pres & Director |
| Mr. Markus M. Meile | Chief Financial Officer |
| Stewart McKelvey | Legal Counsel |
| Dr. Kevin D. Jones | Head of Commercialization and Sr. Director of Sales & Marketing |
Exchange: V
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 43.9508 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 0 |